Gyre Therapeutics, Inc. (GYRE) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 22.52M | 37.2M | 30.56M | 26.77M | 22.06M | 27.87M | 25.49M | 25.23M | 27.17M | 27.15M | 32.04M | 29.33M |
| Revenue Growth % | 2.09% | 33.45% | 19.92% | 6.13% | -18.82% | 2.67% | -20.45% | -13.99% | 8.99% | -4.67% | 9.85% | - |
| Cost of Goods Sold | 1.23M | 1.74M | 1.63M | 1.15M | 894K | 1.18M | 958K | 770K | 979K | 1.25M | 1.18M | 1.08M |
| COGS % of Revenue | 5.45% | 4.69% | 5.33% | 4.3% | 4.05% | 4.22% | 3.76% | 3.05% | 3.6% | 4.6% | 3.7% | 3.67% |
| Gross Profit | 21.29M | 35.45M | 28.94M | 25.62M | 21.16M | 26.7M | 24.53M | 24.45M | 26.19M | 25.9M | 30.86M | 28.25M |
| Gross Margin % | 94.55% | 95.31% | 94.67% | 95.7% | 95.95% | 95.78% | 96.24% | 96.95% | 96.4% | 95.4% | 96.3% | 96.33% |
| Gross Profit Growth % | 0.6% | 32.8% | 17.96% | 4.76% | -19.2% | 3.08% | -20.51% | -13.44% | 10.03% | -4.5% | 11.09% | 42267.16% |
| Operating Expenses | 30.65M | 35.33M | 22.01M | 23.45M | 18.89M | 26.1M | 20.3M | 21.19M | 18.12M | 117.53M | 18.09M | 23.28M |
| OpEx % of Revenue | 136.09% | 94.99% | 72.02% | 87.59% | 85.64% | 93.64% | 79.63% | 84.02% | 66.69% | 432.92% | 56.47% | 79.37% |
| Selling, General & Admin | 21.36M | 30.52M | 19.65M | 20.02M | 15.8M | 22.32M | 17.52M | 17.84M | 15.94M | 26.52M | 15.09M | 19.71M |
| SG&A % of Revenue | 94.84% | 82.05% | 64.28% | 74.79% | 71.61% | 80.08% | 68.75% | 70.72% | 58.66% | 97.68% | 47.08% | 67.2% |
| Research & Development | 6.74M | 4.82M | 2.36M | 3.42M | 3.1M | 3.71M | 2.77M | 3.35M | 2.18M | 4.57M | 3.01M | 3.57M |
| R&D % of Revenue | 29.92% | 12.95% | 7.73% | 12.79% | 14.03% | 13.32% | 10.89% | 13.3% | 8.03% | 16.83% | 9.39% | 12.17% |
| Other Operating Expenses | 1000K | 0 | 1K | 1K | 0 | 66K | 0 | 0 | 0 | 1000K | 0 | 0 |
| Operating Income | -9.36M | 120K | 6.92M | 2.17M | 2.27M | 597K | 4.23M | 3.26M | 8.07M | -91.63M | 12.76M | 4.97M |
| Operating Margin % | -41.54% | 0.32% | 22.66% | 8.11% | 10.3% | 2.14% | 16.61% | 12.93% | 29.7% | -337.53% | 39.84% | 16.96% |
| Operating Income Growth % | -511.57% | -79.9% | 63.6% | -33.45% | -71.84% | 100.65% | -66.84% | -34.42% | 21.11% | -2091.35% | 177.39% | 187.03% |
| EBITDA | -9.36M | 815K | 7.57M | 2.81M | 2.81M | 1.07M | 4.71M | 3.5M | 8.49M | -91.32M | 12.97M | 5.29M |
| EBITDA Margin % | -41.54% | 2.19% | 24.78% | 10.5% | 12.73% | 3.83% | 18.47% | 13.88% | 31.23% | -336.39% | 40.47% | 18.04% |
| EBITDA Growth % | -433.16% | -23.69% | 60.91% | -19.66% | -66.91% | 101.17% | -63.7% | -33.86% | 22.1% | -1989.63% | 167.72% | 193.7% |
| D&A (Non-Cash Add-back) | 0 | 695K | 649K | 641K | 535K | 471K | 474K | 238K | 415K | 308K | 202K | 318K |
| EBIT | -9.36M | 120K | 7.63M | 2.17M | 2.27M | 663K | 4.23M | 3.26M | 8.07M | -5.19M | 12.76M | 4.97M |
| Net Interest Income | 0 | 0 | 200K | 300K | 200K | 346K | 523K | 350K | 328K | 0 | 283K | 0 |
| Interest Income | 0 | 0 | 200K | 300K | 200K | 346K | 523K | 350K | 328K | 0 | 283K | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 118K | -186K | 704K | 67K | 2.36M | 175K | -303K | 2.77M | 4.41M | -8.65M | -1.58M | 880K |
| Pretax Income | -9.24M | -66K | 7.63M | 2.24M | 4.63M | 772K | 3.93M | 6.04M | 12.48M | -100.28M | 11.19M | 5.85M |
| Pretax Margin % | -41.02% | -0.18% | 24.96% | 8.36% | 21.01% | 2.77% | 15.42% | 23.92% | 45.93% | -369.38% | 34.92% | 19.96% |
| Income Tax | -621K | 1.3M | 1.69M | 662K | 901K | 203K | 1.07M | 1.5M | 2.55M | 699K | 3.68M | 2.08M |
| Effective Tax Rate % | 6.72% | -1969.7% | 22.19% | 29.58% | 19.44% | 26.3% | 27.33% | 24.81% | 20.4% | -0.7% | 32.87% | 35.6% |
| Net Income | -8.62M | -1.72M | 3.61M | 442K | 2.7M | -99K | 1.12M | 3.53M | 7.53M | -101.01M | 3.98M | 1.85M |
| Net Margin % | -38.26% | -4.63% | 11.81% | 1.65% | 12.23% | -0.36% | 4.41% | 13.99% | 27.72% | -372.06% | 12.41% | 6.32% |
| Net Income Growth % | -419.35% | -1640.4% | 221.17% | -87.47% | -64.18% | 99.9% | -71.73% | 90.39% | 235.65% | -2802.83% | 219.1% | -96.41% |
| Net Income (Continuing) | -8.62M | -1.37M | 5.94M | 1.58M | 3.73M | 569K | 2.86M | 4.54M | 9.94M | -100.98M | 7.51M | 3.77M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 35.68M | 36.25M | 35.49M | 37.42M | 36.18M | 35.08M | 35.3M | 32.99M | 32.13M | 29.78M | 0 | 0 |
| EPS (Diluted) | -0.10 | -0.02 | 0.03 | 0.00 | 0.00 | -0.16 | 0.05 | 0.03 | 0.07 | -0.68 | 0.05 | 0.08 |
| EPS Growth % | - | 89.56% | -28.48% | -93.49% | -94.14% | 76.47% | -5.97% | -57.64% | -4.3% | -1143.14% | 194.88% | 5.42% |
| EPS (Basic) | -0.10 | -0.02 | 0.04 | 0.01 | 0.03 | -0.19 | 0.06 | 0.04 | 0.09 | -0.68 | 0.05 | 0.08 |
| Diluted Shares Outstanding | 91.34M | 102.94M | 102.7M | 102.7M | 101.97M | 102.29M | 102.64M | 104.33M | 102.59M | 76.6M | 76.6M | 70.09M |
| Basic Shares Outstanding | 91.32M | 91.16M | 89.12M | 89.12M | 86.42M | 85.09M | 85.64M | 85.5M | 83.27M | 76.6M | 76.6M | 69.95M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |